GCTK supply chain intelligence for GlucoTrack, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ARMISTICE-CAPITAL-MASTER-FUND-LTD | ARMISTICE-CAPITAL-MASTER-FUND-LTD | 92% | On December 29, 2025, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Armistice Capital Master Fund Ltd. (also referred to herein as the “Investor”) for a p… |
| INVESTOR | INVESTOR | 92% | The Company entered into a Registration Rights Agreement with the Investor |
| SIXTH-BOROUGH-CAPITAL-FUND-LP | SIXTH-BOROUGH-CAPITAL-FUND-LP | 92% | Under the terms of the ELOC, the Company has the right, but not the obligation, to sell to Sixth Borough, and Sixth Borough is obligated to purchase, up to $ 20.0 million of the Company’s Common Stock |
| DAWSON-JAMES | DAWSON-JAMES | 90% | Dawson James acted as the placement agent for the offerings pursuant to a placement agency agreement, dated February 4, 2025, by and between the Company and Dawson James |
| PAUL-GOODE | PAUL-GOODE | 90% | In consideration for the sale by Dr. Goode of the Purchased Assets to the Company, the Company paid to Dr. Goode cash in the amount of one dollar |
| MASIMO-CORPORATION | MASIMO-CORPORATION | 80% | Ms. Carter currently serves as the SVP of Corporate Development and Strategic Finance for Masimo Corporation |
| MAYO-COLLABORATIVE-SERVICES | MAYO-COLLABORATIVE-SERVICES | 80% | From 2023 to 2025, she served as the Chief Financial Officer for the Mayo Collaborative Services, at the Mayo Clinic |
| MEDTRONIC | MEDTRONIC | 80% | From 2012 until March of 2023, she held various senior roles with Medtronic |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| GCTK-DEBT | Debt stack $3.4M | 90% | Market cache reports total debt of $3.4M. |
| GCTK-DEBT-9734 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2024-12-31. |
| GCTK-DEBT-9733 | Warrants outstanding: 5000 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| GCTK-OWNER-SBI-SECURITIES-CO-LTD | SBI Securities Co., Ltd. | 95% | 13F/ownership overlay lists SBI Securities Co., Ltd.; shares held 9; value $8; as of 2025-12-31. |
| GCTK-OWNER-OSAIC-HOLDINGS-INC | Osaic Holdings Inc. | 95% | 13F/ownership overlay lists Osaic Holdings Inc.; shares held 1; as of 2025-12-31. |
| GCTK-OWNER-BOOTHBAY-FUND-MANAGEMENT-LLC | Boothbay Fund Management, LLC | 95% | 13F/ownership overlay lists Boothbay Fund Management, LLC; shares held 13,525; ownership 1.34%; value $13,392; as of 2025-12-31. |
| GCTK-OWNER-UBS-GROUP-AG | UBS Group AG | 95% | 13F/ownership overlay lists UBS Group AG; shares held 119; ownership 0.01%; value $117; as of 2025-12-31. |
| GCTK-OWNER-BANK-OF-AMERICA-CORPORATION | Bank of America Corporation | 95% | 13F/ownership overlay lists Bank of America Corporation; shares held 28; value $27; as of 2025-12-31. |
| GCTK-OWNER-NEWBRIDGE-FINANCIAL-SERVICES-GROUP-INC | Newbridge Financial Services Group, Inc. | 95% | 13F/ownership overlay lists Newbridge Financial Services Group, Inc.; shares held 34; value $33; as of 2025-12-31. |
| GCTK-OWNER-ALERUS-FINANCIAL-NA | Alerus Financial NA | 95% | 13F/ownership overlay lists Alerus Financial NA; shares held 4,000; ownership 0.40%; value $3,960; as of 2025-12-31. |
| GCTK-OWNER-MORGAN-STANLEY | Morgan Stanley | 95% | 13F/ownership overlay lists Morgan Stanley; shares held 1; as of 2025-12-31. |
| GCTK-OWNER-TOWER-RESEARCH-CAPITAL-LLC-TRC | Tower Research Capital LLC (TRC) | 95% | 13F/ownership overlay lists Tower Research Capital LLC (TRC); shares held 425; ownership 0.04%; value $420; as of 2025-12-31. |
| GCTK-OWNER-IKARIAN-CAPITAL-LLC | Ikarian Capital, LLC | 95% | 13F/ownership overlay lists Ikarian Capital, LLC; shares held 45,830; ownership 4.53%; value $45,380; as of 2025-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 100.00 | 2 | |
| MTLS | Materialise NV | 100.00 | 2 | |
| IVA | Inventiva S.A. | 100.00 | 2 | |
| PSNL | Personalis, Inc. | 100.00 | 2 | |
| NBP | NovaBridge Biosciences | 100.00 | 2 | |
| NVS | Novartis AG | 100.00 | 2 | |
| GIFLF | Grifols, S.A. | 100.00 | 2 | |
| ITGR | Integer Holdings Corporation | 100.00 | 2 | |
| ABT | Abbott Laboratories | 100.00 | 1 | ['receiving'] |
| VTAK | Catheter Precision, Inc. | 100.00 | 2 | |
| GRAL | GRAIL, Inc. | 100.00 | 2 | |
| GRFS | Grifols, S.A. | 100.00 | 2 | |
| SVA | Sinovac Biotech Ltd. | 100.00 | 2 | |
| FLGT | Fulgent Genetics, Inc. | 100.00 | 2 | |
| ALVO | Alvotech | 100.00 | 2 | |
| GIKLY | Grifols, S.A. | 100.00 | 2 | |
| AORT | Artivion, Inc. | 100.00 | 2 | |
| EXAS | Exact Sciences Corp | 100.00 | 2 | |
| GIFOF | Grifols, S.A. | 100.00 | 2 | |
| NSPR | InspireMD, Inc. | 100.00 | 2 |